Flatiron CEO, Carolyn Starrett sat down with and reflected on Flatiron’s last decade and revealed the vision for what’s on the horizon.
bit.ly/3zKaN4
Pinned Tweet
Follow
Flatiron Health
@flatironhealth
We're a healthtech company on a mission to improve and extend lives by learning from the experience of every person with cancer.
Flatiron Health’s Tweets
Our global team collaborated with to create cards to support and brighten the journey of people with cancer.
This #WorldCancerDay learn how organizations around the world are working together to create a future without cancer 3/3 worldcancerday.org
Show this thread
We are generating more actionable evidence to reduce the time to bring therapies to market, better treatment decisions, and drive improved outcomes for patients.
Transforming cancer care takes all of us—and often, the real change is felt at a more personal level. 2/3
1
Show this thread
This year’s #WorldCancerDay theme, #ClosetheCareGap, speaks deeply to our vision: to build a world where technology and science close the gap between care and research. We know the steps required to do just that start with reimagining the infrastructure of cancer care. 1/3
1
2
Show this thread
Our #ClinicalResearch team will be onsite at this year’s !
With prese Booth #1023 cussing trial data management and using RWD to design & execute more optimized trials, we are motivated to solve specific pain points in the CR space.
Join us ➡️ Booth#1023 #SCOPE2023
2
We're excited to announce our presence at this year’s , showcasing how we are leveraging our legacy in point-of-care technology to reimagine how clinical trials are executed.
Join us to learn how our product portfolio is bridging the gap between research and care.
1
Quote Tweet
Large cohort study of pts w/advanced NSCLC showed rapid integration of immune checkpoint inhibitor immunotherapy across all age groups after FDA approval, but improvements in survival were seen in younger patients & not observed in pts 75 & older. ja.ma/403GJRx #LCSM
1
5
Flatiron's employee led Green Task Force exemplifies our corporate value ‘do the right thing.’
To learn how Flatiron employees are finding ways to apply their time, talents, & creativity at work to fight #climatechange, read our newest blog: spkl.io/60174w9sT
1
2
As we continue our impact on #ClinicalResearch, we’re excited to evolve our EDC system beyond traditional EDCs—with greater speed, interoperability, & reliability to get analysis-ready data, sooner.
Learn how our CR offerings are growing in 2023 page.flatiron.com/clinical-resea
Join and for an Oncology Virtual Summit!
Hear from oncology leaders on how innovations in tech and treatment pathways are expanding access to cancer care and achieving health equity for underserved communities.
Register here: events.beckershospitalreview.com/2023-beckers-f
1
1
Flatiron Health CEO Carolyn Starrett has issued a call to the entire healthcare industry: the time to embrace data and technology is now. Read the full transcript of her speech, presented at #HLTH2022, here: spkl.io/60124w334
2
Technology has the power to support changes needed to reduce #clinicalresearch site burden, especially related to data collection. spkl.io/60154ZhAP
Connect with our team to discuss how our EHR-to-EDC tech is changing the future of clinical research
1
1
Integrated evidence and machine learning are opening new doors for the future of #clinicalresearch.
Hear from Principal Quantitative Scientist, on what RWE and innovative methods, such as #MachineLearning, can bring to cancer research in the next 20 years.
1
7
In our final #AIinAction podcast of 2022, Will Shapiro, Head of Data Science at dicusses some of the projects the data science team work on, the progress Flatiron have made within #ML in the past two years & much more
🎧 Listen now 👇👇👇
1
As we reflect on 2022 and look ahead to #2023, we couldn’t be more grateful to all those at Flatiron who have wholeheartedly committed to making a difference across the cancer care ecosystem, from research to the point of care.
Show this thread
At Flatiron, this came in the form of celebrating our 10-year anniversary, evolving our #clinicaltrial solutions, expanding internationally, and using #DataForGood to improve and extend lives by learning from the experience of every person with cancer. ➡️
1
Show this thread
#2022 wasn’t without challenges, but it’s also been full of hope and progress.
We gathered with loved ones, collaborated in the office, embraced flexibility in hybrid work models, engaged with new team members, and found new ways to learn and grow. ➡️
1
2
11
Show this thread
Flatiron CEO, Carolyn Starrett sat down with in one of their recently proclaimed 'Top 25 Stories of 2022.'
Read for a reflection on Flatiron’s last decade and the vision for what’s on the horizon.
2
#ClinicalDecisionSupport at the point of care benefits patients and clinicians alike.
Hear from Medical director , on how #machinelearning can be used as a tool to support decision making for clinicians.
1
2
12
CMO Javier Jimenez, was featured amongst other industry thought leaders in 's “Pharma and RWE: Hitting Its Stride"
Dr. Jimenez discusses RWE’s role in the drug lifecycle, with use cases from #clinicalresearch ➡️#CGDB ➡️ #regulatoryapprovals
1
3
Across our research presented at #ASH22, Flatiron leveraged technology to learn from patients w/ hematologic malignancies, breaking barriers for rare populations to advance research & access to trials.
Read insights from Erlene Seymour, MD, to learn more
2
Congrats to Medical Director, Erlene Seymour for her panel, “Epidemiology: Leveraging Digital Technology to Modernize and Enhance Observational Studies,” at #ASH22!
Interested in learning more about Flatiron authored research? Read insights from Erlene
2
Join today for the “Decentralization and Digitalization: Improving Access with Technology” panel at #ASH22 at 3:15pm CT
Interested in learning more about Flatiron authored research? Read insights from Medical Director, Erlene Seymour
At this year's #ASH22, Flatiron leveraged technology to learn from patients w/ hematologic malignancies, breaking barriers for rare populations to advance research & access to trials.
Read for a sneak peak into the research we're presenting this weekend
1
2
While EHRs are regarded as the definitive record of a person’s history with cancer, they may not capture the full story.
Learn more about how Flatiron is leading innovative approaches to evidence generation through claims-linked data:
1
5
Engineering Manager, Diego Santana, recently contributed to our engineering blog with a new piece on “The Future for Legacy Web Applications” & new frameworks that we use to innovate our web-based system, OncoEMR.
Learn more:
medium.com/flatiron-engin
VP, Research Oncology has been selected as Schafer Memorial Lecture speaker at this year’s for the Cure of GI Cancers at Georgetown University. An incredible opp to discuss the impact of EHR in closing the gap between research and care.
Quote Tweet
Register today for the #RueschSymposium keynote with @NealMeropol of @flatironhealth on Friday, November 18th at 12PM ET. Join us in person or virtually using promo code Guest2022. bit.ly/Ruesch2022.
@LombardiCancer @MedStarGUH @OncLive
1
3
Will you be attending #CNSSummit2022 November 17 - 20?
Don’t miss 's presentation “Using Technology to Integrate Research into Every Day Patient Care” and meet our Clinical Research team at booth #24! #ClincialTrials
Congrats to CEO, Carolyn Starrett, for her presentation at #HLTH2022!
She shared how we're using latest breakthroughs in #realworldevidence, #machinelearning, and #AI to shape the future of cancer care for clinicians, researchers and patients alike.
3
6
Are you at #HLTH2022?
Head to The Seaport Stage at 10:10 AM PST to catch CEO Carolyn Starrett’s presentation “Reimagining the Infrastructure of Cancer Care”
REMINDER: CEO Carolyn Starrett will be presenting TODAY at
🗓️#HLTH2022, The Seaport Stage @ 10:10 AM
Flatiron Health CEO Carolyn Starrett will be presenting at #HLTH2022 tomorrow!
🗓️Join her on The Seaport Stage @ 10:10 AM to learn how Flatiron is using data and technology to reimagine the infrastructure of cancer care.
1
’s spoke w/ on CTAC proposed guidelines for streamlining data collection requirements for clinical trials.
Neal, Co-Chair of the NCI’s Working Group on Streamlining Clinical Trials, shared his thoughts:
cancerletter.com/clinical/20221
1
1
🗓️In less than a week CEO Carolyn Starrett will be presenting at this year's #HLTH2022
Join her on The Seaport Stage at 10:10 AM on Tuesday, 11/15
3
We are so looking forward to CEO Carolyn Starrett's presentation at this year’s , ‘“Reimagining the Infrastructure of Cancer Care through Technology."
🗓️ Join her on the Seaport Stage at 10:10am on Tuesday, November 15
Quote Tweet
T-5 Days until #HLTH2022! 
It's going to be EPIC 
We are expecting 9,500+ health innovators from 47 countries!
From captivating sessions to interactive activations and networking receptions for every audience, we have so much in store for you 
ow.ly/tyun50Lxu0o
It's going to be EPIC
We are expecting 9,500+ health innovators from 47 countries!
From captivating sessions to interactive activations and networking receptions for every audience, we have so much in store for you ow.ly/tyun50Lxu0o
0:30
462 views
1
Visit the Flatiron Evidence Desk to learn more about our compelling research presented at #ISPOREurope 2022, including: Bias characterization of real-world patients with and without imaging in a community oncology Electronic Health Record-derived database.
bit.ly/3zS8cdt
3
10
's spoke to the future of RWD and ML in an #ISPOREurope issue panel, “RWD at Scale: How ML Can Enable Learning from All Patients”
For examples of ML at work, visit the Evidence Desk to learn about our 2022 ISPOR EU research
1
3
Proud of researchers on their #ISPOREurope presentation, 'Comparison of Comorbidity Indices Between EHR Derived Database & Claims Data Among Patients w/ mBC'
Head over to abstract #SA27, or visit bit.ly/3zS8cdt, to learn about the impact of this work!
1
4
Join Carolyn at , where the future of health happens, to learn how the latest breakthroughs in real-world evidence, machine learning, and AI are shaping the future of cancer care for clinicians, researchers and patients alike. #HLTH2022
1
Show this thread